<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">03881</article-id><article-id pub-id-type="doi">10.7554/eLife.03881</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-16089"><name><surname>van Bragt</surname><given-names>Maaike P A</given-names></name><aff><addr-line><named-content content-type="department">Division of Genetics</named-content></addr-line>, <institution>Brigham and Women's Hospital</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16090"><name><surname>Hu</surname><given-names>Xin</given-names></name><aff><addr-line><named-content content-type="department">Division of Genetics</named-content></addr-line>, <institution>Brigham and Women's Hospital</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16091"><name><surname>Xie</surname><given-names>Ying</given-names></name><aff><addr-line><named-content content-type="department">Division of Genetics</named-content></addr-line>, <institution>Brigham and Women's Hospital</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-6334"><name><surname>Li</surname><given-names>Zhe</given-names></name><aff><addr-line><named-content content-type="department">Division of Genetics</named-content></addr-line>, <institution>Brigham and Women's Hospital</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country><email>zli4@rics.bwh.harvard.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1088"><name><surname>Fuchs</surname><given-names>Elaine</given-names></name><role>Reviewing editor</role><aff><institution>Rockefeller University</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>11</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e03881</elocation-id><supplementary-material><ext-link xlink:href="elife-03881-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>04</day><month>07</month><year>2014</year></date><date date-type="accepted"><day>21</day><month>11</month><year>2014</year></date></history><permissions><copyright-statement>Copyright Â© 2014, van Bragt et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>van Bragt et al</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p><italic>RUNX1</italic> encodes a RUNX family transcription factor (TF) and was recently identified as a novel mutated gene in human luminal breast cancers. We found that <italic>Runx1</italic> is expressed in all subpopulations of murine mammary epithelial cells (MECs) except the secretory alveolar luminal cells. Conditional knockout of <italic>Runx1</italic> in MECs by <italic>MMTV-Cre</italic> led to a decrease in luminal MECs, largely due to a profound reduction in the estrogen receptor (ER)-positive mature luminal subpopulation, a phenotype that could be rescued by loss of either <italic>Trp53</italic> or <italic>Rb1</italic>. Mechanistically RUNX1 represses <italic>Elf5</italic>, a master regulatory TF gene for alveolar cells, and regulates mature luminal TF/co-factor genes (e.g., <italic>Foxa1</italic> and <italic>Cited1</italic>) involved in the ER program. Collectively, our data identified a key regulator of the ER<sup>+</sup> luminal lineage whose disruption may contribute to development of ER<sup>+</sup> luminal breast cancer when under the background of either <italic>TP53</italic> or <italic>RB1</italic> loss.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) of Boston Children's Hospital (where the animals are housed) under protocol # 11-10-2034.</p></fn></fn-group></back></article>